conradry commited on
Commit
90afe86
·
verified ·
1 Parent(s): 0a15406

Add the ranked repurposing candidates, evidence views and graph exports

Browse files

Six derived tables from pd_kb.duckdb plus the top-10 shortlist and its mechanism/readout/pathway graphs (GraphML + Mermaid, all under 100 edges).

graphs/pd_pathway_convergence.mmd ADDED
@@ -0,0 +1,131 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ %% Convergent PD pathways: toxin evidence + enrichment
2
+ flowchart LR
3
+ n0[["Parkinson disease"]]
4
+ n1["Detoxification of Reactive Oxygen Species"]
5
+ n2(["CAT"])
6
+ n3(["GPX1"])
7
+ n4(["GPX2"])
8
+ n5(["GPX3"])
9
+ n6(["SOD1"])
10
+ n7(["SOD2"])
11
+ n8(["SOD3"])
12
+ n9{{"chlorpyrifos"}}
13
+ n10{{"lead"}}
14
+ n11{{"manganese"}}
15
+ n12{{"mercury"}}
16
+ n13{{"paraquat"}}
17
+ n14{{"rotenone"}}
18
+ n15["Transcriptional activation of mitochondrial biogenesis"]
19
+ n16(["GABPA"])
20
+ n17(["PPARGC1B"])
21
+ n18{{"tetrachloroethylene"}}
22
+ n19["FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"]
23
+ n20["Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"]
24
+ n21["Interleukin-4 and Interleukin-13 signaling"]
25
+ n22(["AKT1"])
26
+ n23(["BCL2"])
27
+ n24(["IL6"])
28
+ n25(["MAOA"])
29
+ n26(["TNF"])
30
+ n27{{"mptp"}}
31
+ n28{{"trichloroethylene"}}
32
+ n29["Catecholamine biosynthesis"]
33
+ n30(["TH"])
34
+ n31["Biosynthesis of maresin-like SPMs"]
35
+ n32(["CYP2E1"])
36
+ n33["CYP2E1 reactions"]
37
+ n34["Synthesis of 5-eicosatetraenoic acids"]
38
+ n35(["GPX4"])
39
+ n36["Glutathione conjugation"]
40
+ n37(["HPGDS"])
41
+ n38{{"dieldrin"}}
42
+ n39["Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB"]
43
+ n40(["MAOB"])
44
+ n1 -->|q=0.015| n0
45
+ n2 -->|in pathway| n1
46
+ n3 -->|in pathway| n1
47
+ n4 -->|in pathway| n1
48
+ n5 -->|in pathway| n1
49
+ n6 -->|in pathway| n1
50
+ n7 -->|in pathway| n1
51
+ n8 -->|in pathway| n1
52
+ n9 -->|implicates| n1
53
+ n10 -->|implicates| n1
54
+ n11 -->|implicates| n1
55
+ n12 -->|implicates| n1
56
+ n13 -->|implicates| n1
57
+ n14 -->|implicates| n1
58
+ n15 -->|q=0.024| n0
59
+ n16 -->|in pathway| n15
60
+ n17 -->|in pathway| n15
61
+ n7 -->|in pathway| n15
62
+ n9 -->|implicates| n15
63
+ n10 -->|implicates| n15
64
+ n11 -->|implicates| n15
65
+ n12 -->|implicates| n15
66
+ n13 -->|implicates| n15
67
+ n14 -->|implicates| n15
68
+ n18 -->|implicates| n15
69
+ n19 -->|q=0.033| n0
70
+ n2 -->|in pathway| n19
71
+ n7 -->|in pathway| n19
72
+ n9 -->|implicates| n19
73
+ n10 -->|implicates| n19
74
+ n11 -->|implicates| n19
75
+ n12 -->|implicates| n19
76
+ n13 -->|implicates| n19
77
+ n14 -->|implicates| n19
78
+ n20 -->|q=0.015| n0
79
+ n6 -->|in pathway| n20
80
+ n7 -->|in pathway| n20
81
+ n9 -->|implicates| n20
82
+ n10 -->|implicates| n20
83
+ n11 -->|implicates| n20
84
+ n12 -->|implicates| n20
85
+ n13 -->|implicates| n20
86
+ n14 -->|implicates| n20
87
+ n21 -->|q=0.0064| n0
88
+ n22 -->|in pathway| n21
89
+ n23 -->|in pathway| n21
90
+ n24 -->|in pathway| n21
91
+ n25 -->|in pathway| n21
92
+ n26 -->|in pathway| n21
93
+ n27 -->|implicates| n21
94
+ n13 -->|implicates| n21
95
+ n14 -->|implicates| n21
96
+ n28 -->|implicates| n21
97
+ n29 -->|q=0.016| n0
98
+ n30 -->|in pathway| n29
99
+ n27 -->|implicates| n29
100
+ n14 -->|implicates| n29
101
+ n31 -->|q=0.022| n0
102
+ n32 -->|in pathway| n31
103
+ n28 -->|implicates| n31
104
+ n33 -->|q=0.048| n0
105
+ n32 -->|in pathway| n33
106
+ n28 -->|implicates| n33
107
+ n34 -->|q=0.035| n0
108
+ n3 -->|in pathway| n34
109
+ n4 -->|in pathway| n34
110
+ n35 -->|in pathway| n34
111
+ n12 -->|implicates| n34
112
+ n13 -->|implicates| n34
113
+ n36 -->|q=0.022| n0
114
+ n37 -->|in pathway| n36
115
+ n9 -->|implicates| n36
116
+ n38 -->|implicates| n36
117
+ n39 -->|q=0.0064| n0
118
+ n25 -->|in pathway| n39
119
+ n40 -->|in pathway| n39
120
+ n27 -->|implicates| n39
121
+ classDef drug fill:#ddf4ff,stroke:#0969da,color:#0a3069;
122
+ classDef anchor fill:#eeeeee,stroke:#6e7781,color:#24292f,stroke-dasharray:4 3;
123
+ classDef target fill:#fff8c5,stroke:#9a6700,color:#4d2d00;
124
+ classDef toxin fill:#ffebe9,stroke:#cf222e,color:#5a0f14;
125
+ classDef pathway fill:#dafbe1,stroke:#1a7f37,color:#0a3622;
126
+ classDef disease fill:#fbefff,stroke:#8250df,color:#3b1a5c;
127
+ classDef readout fill:#f6f8fa,stroke:#6e7781,color:#24292f;
128
+ class n2,n3,n4,n5,n6,n7,n8,n16,n17,n22,n23,n24,n25,n26,n30,n32,n35,n37,n40 target;
129
+ class n9,n10,n11,n12,n13,n14,n18,n27,n28,n38 toxin;
130
+ class n1,n15,n19,n20,n21,n29,n31,n33,n34,n36,n39 pathway;
131
+ class n0 disease;
graphs/pd_ranking_top10.csv ADDED
@@ -0,0 +1,11 @@
 
 
 
 
 
 
 
 
 
 
 
 
1
+ rank,drug,targets,toxins,modality,verdict,approval_year,priority_score,direction_component,pathway_component,toxin_component,cns_component,clinical_component,biomarker_component,n_protective,n_risk,n_ambiguous,best_pathway_qvalue,n_enriched_pathways,toxin_support,max_toxins_per_target,n_trials,n_late_phase_trials,n_pd_trials,n_neuro_trials,n_disease_readout_trials
2
+ 1,Etanercept,TNF,trichloroethylene; mptp; paraquat; rotenone,biologic,candidate,1998,0.767,1.0,1.0,0.3504,0.7,0.8954,0.2203,1,0,0,0.006420344193912999,1,0.537422,4,354,181,0,5,78
3
+ 2,Adalimumab,TNF,trichloroethylene; mptp; paraquat; rotenone,biologic,candidate,2002,0.6779,1.0,1.0,0.3504,0.15,0.9382,0.2217,1,0,0,0.006420344193912999,1,0.537422,4,469,272,0,0,104
4
+ 3,Infliximab,TNF,trichloroethylene; mptp; paraquat; rotenone,biologic,candidate,1998,0.6698,1.0,1.0,0.3504,0.15,0.8975,0.1643,1,0,0,0.006420344193912999,1,0.537422,4,359,169,0,0,59
5
+ 4,Tranylcypromine,MAOA; MAOB,mptp,small_molecule,candidate,1961,0.6622,1.0,1.0,0.1218,0.7,0.4129,0.0,2,0,0,0.006420344193912999,3,0.186904,1,14,6,0,1,0
6
+ 5,Certolizumab,TNF,trichloroethylene; mptp; paraquat; rotenone,biologic,candidate,2008,0.6529,1.0,1.0,0.3504,0.15,0.7037,0.2,1,0,0,0.006420344193912999,1,0.537422,4,100,61,0,0,20
7
+ 6,Golimumab,TNF,trichloroethylene; mptp; paraquat; rotenone,biologic,candidate,2009,0.6523,1.0,1.0,0.3504,0.15,0.7082,0.1845,1,0,0,0.006420344193912999,1,0.537422,4,103,53,0,0,19
8
+ 7,Moclobemide,MAOA,mptp,small_molecule,candidate,1990,0.6345,1.0,1.0,0.0609,0.7,0.2454,0.0,1,0,0,0.006420344193912999,2,0.093452,1,4,2,0,1,0
9
+ 8,Isocarboxazid,MAOA; MAOB,mptp,small_molecule,candidate,1959,0.6315,1.0,1.0,0.1218,0.7,0.1057,0.0,2,0,0,0.006420344193912999,3,0.186904,1,1,0,0,1,0
10
+ 9,Phenelzine,MAOB; MAOA,mptp,small_molecule,candidate,1961,0.6292,1.0,1.0,0.1218,0.5,0.335,0.125,2,0,0,0.006420344193912999,3,0.186904,1,8,1,0,0,1
11
+ 10,Bupropion,SLC6A3,mptp,small_molecule,candidate,1985,0.6254,1.0,0.5236,0.1168,0.7,0.8915,0.029,1,0,0,0.07114187315128005,0,0.179133,1,345,156,0,8,10
graphs/pd_top10.graphml ADDED
@@ -0,0 +1,472 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <graphml xmlns="http://graphml.graphdrawing.org/xmlns">
3
+ <key id="n_best_pathway_qvalue" for="node" attr.name="best_pathway_qvalue" attr.type="double"/>
4
+ <key id="n_fold_enrichment" for="node" attr.name="fold_enrichment" attr.type="double"/>
5
+ <key id="n_kind" for="node" attr.name="kind" attr.type="string"/>
6
+ <key id="n_label" for="node" attr.name="label" attr.type="string"/>
7
+ <key id="n_modality" for="node" attr.name="modality" attr.type="string"/>
8
+ <key id="n_n_disease_readout_trials" for="node" attr.name="n_disease_readout_trials" attr.type="int"/>
9
+ <key id="n_n_toxins" for="node" attr.name="n_toxins" attr.type="int"/>
10
+ <key id="n_n_trials" for="node" attr.name="n_trials" attr.type="int"/>
11
+ <key id="n_pathway_size" for="node" attr.name="pathway_size" attr.type="int"/>
12
+ <key id="n_priority_score" for="node" attr.name="priority_score" attr.type="double"/>
13
+ <key id="n_qvalue" for="node" attr.name="qvalue" attr.type="double"/>
14
+ <key id="n_rank" for="node" attr.name="rank" attr.type="int"/>
15
+ <key id="n_toxin_support" for="node" attr.name="toxin_support" attr.type="double"/>
16
+ <key id="n_verdict" for="node" attr.name="verdict" attr.type="string"/>
17
+ <key id="e_direction" for="edge" attr.name="direction" attr.type="string"/>
18
+ <key id="e_direction_confidence" for="edge" attr.name="direction_confidence" attr.type="string"/>
19
+ <key id="e_kind" for="edge" attr.name="kind" attr.type="string"/>
20
+ <key id="e_label" for="edge" attr.name="label" attr.type="string"/>
21
+ <key id="e_qvalue" for="edge" attr.name="qvalue" attr.type="double"/>
22
+ <graph id="G" edgedefault="directed">
23
+ <node id="disease:Parkinson disease">
24
+ <data key="n_kind">disease</data>
25
+ <data key="n_label">Parkinson disease</data>
26
+ </node>
27
+ <node id="drug:Etanercept">
28
+ <data key="n_kind">drug</data>
29
+ <data key="n_label">Etanercept</data>
30
+ <data key="n_modality">biologic</data>
31
+ <data key="n_n_disease_readout_trials">78</data>
32
+ <data key="n_n_trials">354</data>
33
+ <data key="n_priority_score">0.767</data>
34
+ <data key="n_rank">1</data>
35
+ <data key="n_verdict">candidate</data>
36
+ </node>
37
+ <node id="target:TNF">
38
+ <data key="n_best_pathway_qvalue">0.006420344193912999</data>
39
+ <data key="n_kind">target</data>
40
+ <data key="n_label">TNF</data>
41
+ <data key="n_n_toxins">4</data>
42
+ <data key="n_toxin_support">0.5374</data>
43
+ </node>
44
+ <node id="toxin:rotenone">
45
+ <data key="n_kind">toxin</data>
46
+ <data key="n_label">rotenone</data>
47
+ </node>
48
+ <node id="toxin:trichloroethylene">
49
+ <data key="n_kind">toxin</data>
50
+ <data key="n_label">trichloroethylene</data>
51
+ </node>
52
+ <node id="toxin:paraquat">
53
+ <data key="n_kind">toxin</data>
54
+ <data key="n_label">paraquat</data>
55
+ </node>
56
+ <node id="toxin:mptp">
57
+ <data key="n_kind">toxin</data>
58
+ <data key="n_label">mptp</data>
59
+ </node>
60
+ <node id="drug:Rasagiline">
61
+ <data key="n_kind">anchor_drug</data>
62
+ <data key="n_label">Rasagiline</data>
63
+ <data key="n_modality">small_molecule</data>
64
+ <data key="n_n_disease_readout_trials">3</data>
65
+ <data key="n_n_trials">51</data>
66
+ <data key="n_priority_score">0.7253</data>
67
+ <data key="n_rank">0</data>
68
+ <data key="n_verdict">established_pd_therapy</data>
69
+ </node>
70
+ <node id="target:MAOB">
71
+ <data key="n_best_pathway_qvalue">0.006420344193912999</data>
72
+ <data key="n_kind">target</data>
73
+ <data key="n_label">MAOB</data>
74
+ <data key="n_n_toxins">1</data>
75
+ <data key="n_toxin_support">0.0935</data>
76
+ </node>
77
+ <node id="drug:Safinamide">
78
+ <data key="n_kind">anchor_drug</data>
79
+ <data key="n_label">Safinamide</data>
80
+ <data key="n_modality">small_molecule</data>
81
+ <data key="n_n_disease_readout_trials">0</data>
82
+ <data key="n_n_trials">25</data>
83
+ <data key="n_priority_score">0.7106</data>
84
+ <data key="n_rank">0</data>
85
+ <data key="n_verdict">established_pd_therapy</data>
86
+ </node>
87
+ <node id="drug:Adalimumab">
88
+ <data key="n_kind">drug</data>
89
+ <data key="n_label">Adalimumab</data>
90
+ <data key="n_modality">biologic</data>
91
+ <data key="n_n_disease_readout_trials">104</data>
92
+ <data key="n_n_trials">469</data>
93
+ <data key="n_priority_score">0.6779</data>
94
+ <data key="n_rank">2</data>
95
+ <data key="n_verdict">candidate</data>
96
+ </node>
97
+ <node id="drug:Methylphenidate">
98
+ <data key="n_kind">anchor_drug</data>
99
+ <data key="n_label">Methylphenidate</data>
100
+ <data key="n_modality">small_molecule</data>
101
+ <data key="n_n_disease_readout_trials">6</data>
102
+ <data key="n_n_trials">389</data>
103
+ <data key="n_priority_score">0.6773</data>
104
+ <data key="n_rank">0</data>
105
+ <data key="n_verdict">established_pd_therapy</data>
106
+ </node>
107
+ <node id="target:SLC6A3">
108
+ <data key="n_best_pathway_qvalue">0.07114187315128005</data>
109
+ <data key="n_kind">target</data>
110
+ <data key="n_label">SLC6A3</data>
111
+ <data key="n_n_toxins">1</data>
112
+ <data key="n_toxin_support">0.1791</data>
113
+ </node>
114
+ <node id="drug:Infliximab">
115
+ <data key="n_kind">drug</data>
116
+ <data key="n_label">Infliximab</data>
117
+ <data key="n_modality">biologic</data>
118
+ <data key="n_n_disease_readout_trials">59</data>
119
+ <data key="n_n_trials">359</data>
120
+ <data key="n_priority_score">0.6698</data>
121
+ <data key="n_rank">3</data>
122
+ <data key="n_verdict">candidate</data>
123
+ </node>
124
+ <node id="drug:Tranylcypromine">
125
+ <data key="n_kind">drug</data>
126
+ <data key="n_label">Tranylcypromine</data>
127
+ <data key="n_modality">small_molecule</data>
128
+ <data key="n_n_disease_readout_trials">0</data>
129
+ <data key="n_n_trials">14</data>
130
+ <data key="n_priority_score">0.6622</data>
131
+ <data key="n_rank">4</data>
132
+ <data key="n_verdict">candidate</data>
133
+ </node>
134
+ <node id="target:MAOA">
135
+ <data key="n_best_pathway_qvalue">0.006420344193912999</data>
136
+ <data key="n_kind">target</data>
137
+ <data key="n_label">MAOA</data>
138
+ <data key="n_n_toxins">1</data>
139
+ <data key="n_toxin_support">0.0935</data>
140
+ </node>
141
+ <node id="drug:Certolizumab">
142
+ <data key="n_kind">drug</data>
143
+ <data key="n_label">Certolizumab</data>
144
+ <data key="n_modality">biologic</data>
145
+ <data key="n_n_disease_readout_trials">20</data>
146
+ <data key="n_n_trials">100</data>
147
+ <data key="n_priority_score">0.6529</data>
148
+ <data key="n_rank">5</data>
149
+ <data key="n_verdict">candidate</data>
150
+ </node>
151
+ <node id="drug:Golimumab">
152
+ <data key="n_kind">drug</data>
153
+ <data key="n_label">Golimumab</data>
154
+ <data key="n_modality">biologic</data>
155
+ <data key="n_n_disease_readout_trials">19</data>
156
+ <data key="n_n_trials">103</data>
157
+ <data key="n_priority_score">0.6523</data>
158
+ <data key="n_rank">6</data>
159
+ <data key="n_verdict">candidate</data>
160
+ </node>
161
+ <node id="drug:Moclobemide">
162
+ <data key="n_kind">drug</data>
163
+ <data key="n_label">Moclobemide</data>
164
+ <data key="n_modality">small_molecule</data>
165
+ <data key="n_n_disease_readout_trials">0</data>
166
+ <data key="n_n_trials">4</data>
167
+ <data key="n_priority_score">0.6345</data>
168
+ <data key="n_rank">7</data>
169
+ <data key="n_verdict">candidate</data>
170
+ </node>
171
+ <node id="drug:Isocarboxazid">
172
+ <data key="n_kind">drug</data>
173
+ <data key="n_label">Isocarboxazid</data>
174
+ <data key="n_modality">small_molecule</data>
175
+ <data key="n_n_disease_readout_trials">0</data>
176
+ <data key="n_n_trials">1</data>
177
+ <data key="n_priority_score">0.6315</data>
178
+ <data key="n_rank">8</data>
179
+ <data key="n_verdict">candidate</data>
180
+ </node>
181
+ <node id="drug:Phenelzine">
182
+ <data key="n_kind">drug</data>
183
+ <data key="n_label">Phenelzine</data>
184
+ <data key="n_modality">small_molecule</data>
185
+ <data key="n_n_disease_readout_trials">1</data>
186
+ <data key="n_n_trials">8</data>
187
+ <data key="n_priority_score">0.6292</data>
188
+ <data key="n_rank">9</data>
189
+ <data key="n_verdict">candidate</data>
190
+ </node>
191
+ <node id="drug:Bupropion">
192
+ <data key="n_kind">drug</data>
193
+ <data key="n_label">Bupropion</data>
194
+ <data key="n_modality">small_molecule</data>
195
+ <data key="n_n_disease_readout_trials">10</data>
196
+ <data key="n_n_trials">345</data>
197
+ <data key="n_priority_score">0.6254</data>
198
+ <data key="n_rank">10</data>
199
+ <data key="n_verdict">candidate</data>
200
+ </node>
201
+ <node id="pathway:Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB">
202
+ <data key="n_fold_enrichment">120.5444</data>
203
+ <data key="n_kind">pathway</data>
204
+ <data key="n_label">Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB</data>
205
+ <data key="n_pathway_size">2</data>
206
+ <data key="n_qvalue">0.006420344193912999</data>
207
+ </node>
208
+ <node id="pathway:Interleukin-4 and Interleukin-13 signaling">
209
+ <data key="n_fold_enrichment">7.8131</data>
210
+ <data key="n_kind">pathway</data>
211
+ <data key="n_label">Interleukin-4 and Interleukin-13 signaling</data>
212
+ <data key="n_pathway_size">108</data>
213
+ <data key="n_qvalue">0.006420344193912999</data>
214
+ </node>
215
+ <edge id="e0" source="drug:Etanercept" target="target:TNF">
216
+ <data key="e_direction">protective</data>
217
+ <data key="e_direction_confidence">plausible</data>
218
+ <data key="e_kind">acts_on</data>
219
+ <data key="e_label">inhibitor</data>
220
+ </edge>
221
+ <edge id="e1" source="toxin:rotenone" target="target:TNF">
222
+ <data key="e_kind">implicates</data>
223
+ <data key="e_label">implicates</data>
224
+ </edge>
225
+ <edge id="e2" source="toxin:trichloroethylene" target="target:TNF">
226
+ <data key="e_kind">implicates</data>
227
+ <data key="e_label">implicates</data>
228
+ </edge>
229
+ <edge id="e3" source="toxin:paraquat" target="target:TNF">
230
+ <data key="e_kind">implicates</data>
231
+ <data key="e_label">implicates</data>
232
+ </edge>
233
+ <edge id="e4" source="toxin:mptp" target="target:TNF">
234
+ <data key="e_kind">implicates</data>
235
+ <data key="e_label">implicates</data>
236
+ </edge>
237
+ <edge id="e5" source="drug:Rasagiline" target="target:MAOB">
238
+ <data key="e_direction">protective</data>
239
+ <data key="e_direction_confidence">established</data>
240
+ <data key="e_kind">acts_on</data>
241
+ <data key="e_label">inhibitor</data>
242
+ </edge>
243
+ <edge id="e6" source="toxin:mptp" target="target:MAOB">
244
+ <data key="e_kind">implicates</data>
245
+ <data key="e_label">implicates</data>
246
+ </edge>
247
+ <edge id="e7" source="drug:Safinamide" target="target:MAOB">
248
+ <data key="e_direction">protective</data>
249
+ <data key="e_direction_confidence">established</data>
250
+ <data key="e_kind">acts_on</data>
251
+ <data key="e_label">inhibitor</data>
252
+ </edge>
253
+ <edge id="e8" source="toxin:mptp" target="target:MAOB">
254
+ <data key="e_kind">implicates</data>
255
+ <data key="e_label">implicates</data>
256
+ </edge>
257
+ <edge id="e9" source="drug:Adalimumab" target="target:TNF">
258
+ <data key="e_direction">protective</data>
259
+ <data key="e_direction_confidence">plausible</data>
260
+ <data key="e_kind">acts_on</data>
261
+ <data key="e_label">inhibitor</data>
262
+ </edge>
263
+ <edge id="e10" source="toxin:rotenone" target="target:TNF">
264
+ <data key="e_kind">implicates</data>
265
+ <data key="e_label">implicates</data>
266
+ </edge>
267
+ <edge id="e11" source="toxin:trichloroethylene" target="target:TNF">
268
+ <data key="e_kind">implicates</data>
269
+ <data key="e_label">implicates</data>
270
+ </edge>
271
+ <edge id="e12" source="toxin:paraquat" target="target:TNF">
272
+ <data key="e_kind">implicates</data>
273
+ <data key="e_label">implicates</data>
274
+ </edge>
275
+ <edge id="e13" source="toxin:mptp" target="target:TNF">
276
+ <data key="e_kind">implicates</data>
277
+ <data key="e_label">implicates</data>
278
+ </edge>
279
+ <edge id="e14" source="drug:Methylphenidate" target="target:SLC6A3">
280
+ <data key="e_direction">protective</data>
281
+ <data key="e_direction_confidence">plausible</data>
282
+ <data key="e_kind">acts_on</data>
283
+ <data key="e_label">inhibitor</data>
284
+ </edge>
285
+ <edge id="e15" source="toxin:mptp" target="target:SLC6A3">
286
+ <data key="e_kind">implicates</data>
287
+ <data key="e_label">implicates</data>
288
+ </edge>
289
+ <edge id="e16" source="drug:Infliximab" target="target:TNF">
290
+ <data key="e_direction">protective</data>
291
+ <data key="e_direction_confidence">plausible</data>
292
+ <data key="e_kind">acts_on</data>
293
+ <data key="e_label">inhibitor</data>
294
+ </edge>
295
+ <edge id="e17" source="toxin:rotenone" target="target:TNF">
296
+ <data key="e_kind">implicates</data>
297
+ <data key="e_label">implicates</data>
298
+ </edge>
299
+ <edge id="e18" source="toxin:trichloroethylene" target="target:TNF">
300
+ <data key="e_kind">implicates</data>
301
+ <data key="e_label">implicates</data>
302
+ </edge>
303
+ <edge id="e19" source="toxin:paraquat" target="target:TNF">
304
+ <data key="e_kind">implicates</data>
305
+ <data key="e_label">implicates</data>
306
+ </edge>
307
+ <edge id="e20" source="toxin:mptp" target="target:TNF">
308
+ <data key="e_kind">implicates</data>
309
+ <data key="e_label">implicates</data>
310
+ </edge>
311
+ <edge id="e21" source="drug:Tranylcypromine" target="target:MAOA">
312
+ <data key="e_direction">protective</data>
313
+ <data key="e_direction_confidence">plausible</data>
314
+ <data key="e_kind">acts_on</data>
315
+ <data key="e_label">inhibitor</data>
316
+ </edge>
317
+ <edge id="e22" source="toxin:mptp" target="target:MAOA">
318
+ <data key="e_kind">implicates</data>
319
+ <data key="e_label">implicates</data>
320
+ </edge>
321
+ <edge id="e23" source="drug:Tranylcypromine" target="target:MAOB">
322
+ <data key="e_direction">protective</data>
323
+ <data key="e_direction_confidence">established</data>
324
+ <data key="e_kind">acts_on</data>
325
+ <data key="e_label">inhibitor</data>
326
+ </edge>
327
+ <edge id="e24" source="toxin:mptp" target="target:MAOB">
328
+ <data key="e_kind">implicates</data>
329
+ <data key="e_label">implicates</data>
330
+ </edge>
331
+ <edge id="e25" source="drug:Certolizumab" target="target:TNF">
332
+ <data key="e_direction">protective</data>
333
+ <data key="e_direction_confidence">plausible</data>
334
+ <data key="e_kind">acts_on</data>
335
+ <data key="e_label">inhibitor</data>
336
+ </edge>
337
+ <edge id="e26" source="toxin:rotenone" target="target:TNF">
338
+ <data key="e_kind">implicates</data>
339
+ <data key="e_label">implicates</data>
340
+ </edge>
341
+ <edge id="e27" source="toxin:trichloroethylene" target="target:TNF">
342
+ <data key="e_kind">implicates</data>
343
+ <data key="e_label">implicates</data>
344
+ </edge>
345
+ <edge id="e28" source="toxin:paraquat" target="target:TNF">
346
+ <data key="e_kind">implicates</data>
347
+ <data key="e_label">implicates</data>
348
+ </edge>
349
+ <edge id="e29" source="toxin:mptp" target="target:TNF">
350
+ <data key="e_kind">implicates</data>
351
+ <data key="e_label">implicates</data>
352
+ </edge>
353
+ <edge id="e30" source="drug:Golimumab" target="target:TNF">
354
+ <data key="e_direction">protective</data>
355
+ <data key="e_direction_confidence">plausible</data>
356
+ <data key="e_kind">acts_on</data>
357
+ <data key="e_label">inhibitor</data>
358
+ </edge>
359
+ <edge id="e31" source="toxin:rotenone" target="target:TNF">
360
+ <data key="e_kind">implicates</data>
361
+ <data key="e_label">implicates</data>
362
+ </edge>
363
+ <edge id="e32" source="toxin:trichloroethylene" target="target:TNF">
364
+ <data key="e_kind">implicates</data>
365
+ <data key="e_label">implicates</data>
366
+ </edge>
367
+ <edge id="e33" source="toxin:paraquat" target="target:TNF">
368
+ <data key="e_kind">implicates</data>
369
+ <data key="e_label">implicates</data>
370
+ </edge>
371
+ <edge id="e34" source="toxin:mptp" target="target:TNF">
372
+ <data key="e_kind">implicates</data>
373
+ <data key="e_label">implicates</data>
374
+ </edge>
375
+ <edge id="e35" source="drug:Moclobemide" target="target:MAOA">
376
+ <data key="e_direction">protective</data>
377
+ <data key="e_direction_confidence">plausible</data>
378
+ <data key="e_kind">acts_on</data>
379
+ <data key="e_label">inhibitor</data>
380
+ </edge>
381
+ <edge id="e36" source="toxin:mptp" target="target:MAOA">
382
+ <data key="e_kind">implicates</data>
383
+ <data key="e_label">implicates</data>
384
+ </edge>
385
+ <edge id="e37" source="drug:Isocarboxazid" target="target:MAOA">
386
+ <data key="e_direction">protective</data>
387
+ <data key="e_direction_confidence">plausible</data>
388
+ <data key="e_kind">acts_on</data>
389
+ <data key="e_label">inhibitor</data>
390
+ </edge>
391
+ <edge id="e38" source="toxin:mptp" target="target:MAOA">
392
+ <data key="e_kind">implicates</data>
393
+ <data key="e_label">implicates</data>
394
+ </edge>
395
+ <edge id="e39" source="drug:Isocarboxazid" target="target:MAOB">
396
+ <data key="e_direction">protective</data>
397
+ <data key="e_direction_confidence">established</data>
398
+ <data key="e_kind">acts_on</data>
399
+ <data key="e_label">inhibitor</data>
400
+ </edge>
401
+ <edge id="e40" source="toxin:mptp" target="target:MAOB">
402
+ <data key="e_kind">implicates</data>
403
+ <data key="e_label">implicates</data>
404
+ </edge>
405
+ <edge id="e41" source="drug:Phenelzine" target="target:MAOA">
406
+ <data key="e_direction">protective</data>
407
+ <data key="e_direction_confidence">plausible</data>
408
+ <data key="e_kind">acts_on</data>
409
+ <data key="e_label">inhibitor</data>
410
+ </edge>
411
+ <edge id="e42" source="toxin:mptp" target="target:MAOA">
412
+ <data key="e_kind">implicates</data>
413
+ <data key="e_label">implicates</data>
414
+ </edge>
415
+ <edge id="e43" source="drug:Phenelzine" target="target:MAOB">
416
+ <data key="e_direction">protective</data>
417
+ <data key="e_direction_confidence">established</data>
418
+ <data key="e_kind">acts_on</data>
419
+ <data key="e_label">inhibitor</data>
420
+ </edge>
421
+ <edge id="e44" source="toxin:mptp" target="target:MAOB">
422
+ <data key="e_kind">implicates</data>
423
+ <data key="e_label">implicates</data>
424
+ </edge>
425
+ <edge id="e45" source="drug:Bupropion" target="target:SLC6A3">
426
+ <data key="e_direction">protective</data>
427
+ <data key="e_direction_confidence">plausible</data>
428
+ <data key="e_kind">acts_on</data>
429
+ <data key="e_label">inhibitor</data>
430
+ </edge>
431
+ <edge id="e46" source="toxin:mptp" target="target:SLC6A3">
432
+ <data key="e_kind">implicates</data>
433
+ <data key="e_label">implicates</data>
434
+ </edge>
435
+ <edge id="e47" source="target:MAOA" target="pathway:Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB">
436
+ <data key="e_kind">member_of</data>
437
+ <data key="e_label">in pathway</data>
438
+ </edge>
439
+ <edge id="e48" source="pathway:Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB" target="disease:Parkinson disease">
440
+ <data key="e_kind">enriched_in</data>
441
+ <data key="e_label">q=0.0064</data>
442
+ <data key="e_qvalue">0.006420344193912999</data>
443
+ </edge>
444
+ <edge id="e49" source="target:MAOA" target="pathway:Interleukin-4 and Interleukin-13 signaling">
445
+ <data key="e_kind">member_of</data>
446
+ <data key="e_label">in pathway</data>
447
+ </edge>
448
+ <edge id="e50" source="pathway:Interleukin-4 and Interleukin-13 signaling" target="disease:Parkinson disease">
449
+ <data key="e_kind">enriched_in</data>
450
+ <data key="e_label">q=0.0064</data>
451
+ <data key="e_qvalue">0.006420344193912999</data>
452
+ </edge>
453
+ <edge id="e51" source="target:MAOB" target="pathway:Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB">
454
+ <data key="e_kind">member_of</data>
455
+ <data key="e_label">in pathway</data>
456
+ </edge>
457
+ <edge id="e52" source="pathway:Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB" target="disease:Parkinson disease">
458
+ <data key="e_kind">enriched_in</data>
459
+ <data key="e_label">q=0.0064</data>
460
+ <data key="e_qvalue">0.006420344193912999</data>
461
+ </edge>
462
+ <edge id="e53" source="target:TNF" target="pathway:Interleukin-4 and Interleukin-13 signaling">
463
+ <data key="e_kind">member_of</data>
464
+ <data key="e_label">in pathway</data>
465
+ </edge>
466
+ <edge id="e54" source="pathway:Interleukin-4 and Interleukin-13 signaling" target="disease:Parkinson disease">
467
+ <data key="e_kind">enriched_in</data>
468
+ <data key="e_label">q=0.0064</data>
469
+ <data key="e_qvalue">0.006420344193912999</data>
470
+ </edge>
471
+ </graph>
472
+ </graphml>
graphs/pd_top10_mechanism.mmd ADDED
@@ -0,0 +1,94 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ %% Top PD repurposing candidates: toxin, target and pathway evidence
2
+ flowchart LR
3
+ n0[["Parkinson disease"]]
4
+ n1["1. Etanercept"]
5
+ n2(["TNF"])
6
+ n3{{"rotenone"}}
7
+ n4{{"trichloroethylene"}}
8
+ n5{{"paraquat"}}
9
+ n6{{"mptp"}}
10
+ n7["Rasagiline (approved for PD)"]
11
+ n8(["MAOB"])
12
+ n9["Safinamide (approved for PD)"]
13
+ n10["2. Adalimumab"]
14
+ n11["Methylphenidate (approved for PD)"]
15
+ n12(["SLC6A3"])
16
+ n13["3. Infliximab"]
17
+ n14["4. Tranylcypromine"]
18
+ n15(["MAOA"])
19
+ n16["5. Certolizumab"]
20
+ n17["6. Golimumab"]
21
+ n18["7. Moclobemide"]
22
+ n19["8. Isocarboxazid"]
23
+ n20["9. Phenelzine"]
24
+ n21["10. Bupropion"]
25
+ n22["Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB"]
26
+ n23["Interleukin-4 and Interleukin-13 signaling"]
27
+ n1 -->|inhibitor| n2
28
+ n3 -->|implicates| n2
29
+ n4 -->|implicates| n2
30
+ n5 -->|implicates| n2
31
+ n6 -->|implicates| n2
32
+ n7 -->|inhibitor| n8
33
+ n6 -->|implicates| n8
34
+ n9 -->|inhibitor| n8
35
+ n6 -->|implicates| n8
36
+ n10 -->|inhibitor| n2
37
+ n3 -->|implicates| n2
38
+ n4 -->|implicates| n2
39
+ n5 -->|implicates| n2
40
+ n6 -->|implicates| n2
41
+ n11 -->|inhibitor| n12
42
+ n6 -->|implicates| n12
43
+ n13 -->|inhibitor| n2
44
+ n3 -->|implicates| n2
45
+ n4 -->|implicates| n2
46
+ n5 -->|implicates| n2
47
+ n6 -->|implicates| n2
48
+ n14 -->|inhibitor| n15
49
+ n6 -->|implicates| n15
50
+ n14 -->|inhibitor| n8
51
+ n6 -->|implicates| n8
52
+ n16 -->|inhibitor| n2
53
+ n3 -->|implicates| n2
54
+ n4 -->|implicates| n2
55
+ n5 -->|implicates| n2
56
+ n6 -->|implicates| n2
57
+ n17 -->|inhibitor| n2
58
+ n3 -->|implicates| n2
59
+ n4 -->|implicates| n2
60
+ n5 -->|implicates| n2
61
+ n6 -->|implicates| n2
62
+ n18 -->|inhibitor| n15
63
+ n6 -->|implicates| n15
64
+ n19 -->|inhibitor| n15
65
+ n6 -->|implicates| n15
66
+ n19 -->|inhibitor| n8
67
+ n6 -->|implicates| n8
68
+ n20 -->|inhibitor| n15
69
+ n6 -->|implicates| n15
70
+ n20 -->|inhibitor| n8
71
+ n6 -->|implicates| n8
72
+ n21 -->|inhibitor| n12
73
+ n6 -->|implicates| n12
74
+ n15 -->|in pathway| n22
75
+ n22 -->|q=0.0064| n0
76
+ n15 -->|in pathway| n23
77
+ n23 -->|q=0.0064| n0
78
+ n8 -->|in pathway| n22
79
+ n22 -->|q=0.0064| n0
80
+ n2 -->|in pathway| n23
81
+ n23 -->|q=0.0064| n0
82
+ classDef drug fill:#ddf4ff,stroke:#0969da,color:#0a3069;
83
+ classDef anchor fill:#eeeeee,stroke:#6e7781,color:#24292f,stroke-dasharray:4 3;
84
+ classDef target fill:#fff8c5,stroke:#9a6700,color:#4d2d00;
85
+ classDef toxin fill:#ffebe9,stroke:#cf222e,color:#5a0f14;
86
+ classDef pathway fill:#dafbe1,stroke:#1a7f37,color:#0a3622;
87
+ classDef disease fill:#fbefff,stroke:#8250df,color:#3b1a5c;
88
+ classDef readout fill:#f6f8fa,stroke:#6e7781,color:#24292f;
89
+ class n1,n10,n13,n14,n16,n17,n18,n19,n20,n21 drug;
90
+ class n7,n9,n11 anchor;
91
+ class n2,n8,n12,n15 target;
92
+ class n3,n4,n5,n6 toxin;
93
+ class n22,n23 pathway;
94
+ class n0 disease;
graphs/pd_top10_readouts.mmd ADDED
@@ -0,0 +1,45 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ %% Disease-relevant biomarker readouts (PK excluded)
2
+ flowchart LR
3
+ n0["2. Adalimumab"]
4
+ n1("inflammation")
5
+ n2["1. Etanercept"]
6
+ n3["3. Infliximab"]
7
+ n4("other_biomarker")
8
+ n5["5. Certolizumab"]
9
+ n6["6. Golimumab"]
10
+ n7["10. Bupropion"]
11
+ n8("genomic")
12
+ n9("fluid_molecular")
13
+ n10("imaging")
14
+ n11["9. Phenelzine"]
15
+ n0 -->|87 trials| n1
16
+ n2 -->|64 trials| n1
17
+ n3 -->|43 trials| n1
18
+ n0 -->|20 trials| n4
19
+ n5 -->|18 trials| n1
20
+ n3 -->|15 trials| n4
21
+ n6 -->|14 trials| n1
22
+ n2 -->|10 trials| n4
23
+ n7 -->|5 trials| n1
24
+ n7 -->|5 trials| n4
25
+ n2 -->|5 trials| n8
26
+ n6 -->|4 trials| n4
27
+ n3 -->|3 trials| n8
28
+ n5 -->|2 trials| n4
29
+ n2 -->|2 trials| n9
30
+ n0 -->|2 trials| n8
31
+ n6 -->|1 trials| n9
32
+ n3 -->|1 trials| n9
33
+ n0 -->|1 trials| n10
34
+ n2 -->|1 trials| n10
35
+ n11 -->|1 trials| n8
36
+ n0 -->|1 trials| n9
37
+ classDef drug fill:#ddf4ff,stroke:#0969da,color:#0a3069;
38
+ classDef anchor fill:#eeeeee,stroke:#6e7781,color:#24292f,stroke-dasharray:4 3;
39
+ classDef target fill:#fff8c5,stroke:#9a6700,color:#4d2d00;
40
+ classDef toxin fill:#ffebe9,stroke:#cf222e,color:#5a0f14;
41
+ classDef pathway fill:#dafbe1,stroke:#1a7f37,color:#0a3622;
42
+ classDef disease fill:#fbefff,stroke:#8250df,color:#3b1a5c;
43
+ classDef readout fill:#f6f8fa,stroke:#6e7781,color:#24292f;
44
+ class n0,n2,n3,n5,n6,n7,n11 drug;
45
+ class n1,n4,n8,n9,n10 readout;
pd_drug_biomarker_readouts.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:91775c706d3a9a4904093ca9bdb350cda81a6a80a49663da5d8180c5fdaac3ee
3
+ size 5623
pd_drug_candidates.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:e5529a56791aff902518f2bd5cb9a7e6b5c855d367f0ad2090a2aaa34dc7d5bf
3
+ size 13940
pd_drug_target_evidence.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:a371ea6376d99dc34b6e2ae6ffbf6da5bd93393d20f5ab7b79141cdd71c00118
3
+ size 10137
pd_pathway_evidence.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:fbaa431f9d6b5021cc60fb3feff73e855e31fc1e44c605d626d4453fa80f46b5
3
+ size 13933
pd_ranking_top10.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:b4307434816cd7ea5def90a95f6d96097bcd56e9f82ef6e64c282e3496d5c599
3
+ size 8200
pd_undrugged_targets.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:298cce2bad8eca452f0f879bb2d725c7cf8ac81bd4e0b667ff81ddd03af7d67f
3
+ size 5227